Nawaloka Hospitals PLC
Nawaloka Hospitals PLC operates as a provider of healthcare services in Sri Lanka, generating revenue primarily through hospital operations and outpatient services.
Business. Nawaloka Hospitals PLC (NHL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker NHL.CM. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Nawaloka Hospitals PLC (NHL.CM) operates in the Healthcare Facilities & Services industry, providing healthcare services and equipment. The company is headquartered in Sri Lanka and is listed on the Colombo Stock Exchange under the ticker NHL.CM. Specific details regarding its operating segments and geographic revenue mix are not available.
Nawaloka Hospitals PLC has a debt-to-equity ratio of 1.58, indicating a relatively high level of leverage, and a current ratio of 0.32, suggesting limited short-term liquidity. The company's free cash flow of 541.7 million LKR supports operational flexibility, but its operating cash flow of 1.13 billion LKR is partially offset by capital expenditures of -340.7 million LKR.
The company's return on equity (ROE) is 1.15%, and return on assets (ROA) is 0.28%, both of which are below the typical performance benchmarks for the healthcare sector, indicating suboptimal capital efficiency. These metrics suggest that the company is not generating strong returns relative to its equity and asset base.
Nawaloka Hospitals PLC's revenue is concentrated in Sri Lanka, with no disclosed international operations. The company's business is primarily driven by domestic healthcare demand, and there is no indication of diversified geographic exposure. This concentration increases vulnerability to local economic and regulatory shifts.
The company's growth trajectory is modest, with no disclosed revenue growth rates or future projections. Historical revenue of 11.01 billion LKR reflects stable operations but lacks evidence of significant expansion. The absence of clear growth drivers or strategic initiatives limits visibility into future performance.
The company faces medium liquidity risk due to its current ratio of 0.32 and a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no recent or disclosed share issuance activity. However, the high debt-to-equity ratio of 1.58 suggests potential refinancing risks in the medium term.
No recent events, such as filings or transcripts, have been disclosed in the available data. The company's financial and operational updates are limited to standard financial reporting, with no material developments reported in the latest available documents.
- Nawaloka Hospitals PLC has a high debt-to-equity ratio of 1.58, indicating significant leverage.
- The company's ROE of 1.15% and ROA of 0.28% are below typical healthcare sector benchmarks.
- Revenue is concentrated in Sri Lanka, with no international diversification.
- Free cash flow of 541.7 million LKR supports operations, but capital expenditures are a drag.
- Liquidity risk is medium, and dilution risk is low based on current financials.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Nawaloka Hospitals PLC Market data — financials · 2026-05-28